Update on the use of immunoglobulin in human disease: a review of evidence
EE Perez, JS Orange, F Bonilla, J Chinen… - Journal of Allergy and …, 2017 - Elsevier
Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
International consensus statement on allergy and rhinology: rhinosinusitis
RR Orlandi, TT Kingdom, PH Hwang… - International forum of …, 2016 - Wiley Online Library
Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham,
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …
International Consensus Document (ICON): common variable immunodeficiency disorders
FA Bonilla, I Barlan, H Chapel… - The Journal of …, 2016 - jaci-inpractice.org
The International Collaboration in Asthma, Allergy and Immunology initiated an international
coalition among the American Academy of Allergy, Asthma & Immunology; the European …
coalition among the American Academy of Allergy, Asthma & Immunology; the European …
[HTML][HTML] Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) is a recently
described combined immunodeficiency resulting from gain-of-function mutations in PIK3CD …
described combined immunodeficiency resulting from gain-of-function mutations in PIK3CD …
European position paper on rhinosinusitis and nasal polyps 2012
WJ Fokkens, VI Lund, J Mullol, C Bachert, I Alobid… - Rhinology, 2012 - biblio.ugent.be
The methodology for EPOS2012 has been the same as for the other two productions.
Leaders in the field were invited to critically appraise the literature and write a report on a …
Leaders in the field were invited to critically appraise the literature and write a report on a …
Clinical picture and treatment of 2212 patients with common variable immunodeficiency
B Gathmann, N Mahlaoui, L Gérard… - Journal of Allergy and …, 2014 - Elsevier
Background Common variable immunodeficiency (CVID) is an antibody deficiency with an
equal sex distribution and a high variability in clinical presentation. The main features …
equal sex distribution and a high variability in clinical presentation. The main features …
Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis
H Ho, C Cunningham-Rundles - Frontiers in immunology, 2020 - frontiersin.org
Non-infectious complications in common variable immunodeficiency (CVID) have emerged
as a major clinical challenge. Detailed clinical spectrum, organ-specific pathologies and …
as a major clinical challenge. Detailed clinical spectrum, organ-specific pathologies and …
IgG placental transfer in healthy and pathological pregnancies
P Palmeira, C Quinello… - Journal of …, 2012 - Wiley Online Library
Placental transfer of maternal IgG antibodies to the fetus is an important mechanism that
provides protection to the infant while his/her humoral response is inefficient. IgG is the only …
provides protection to the infant while his/her humoral response is inefficient. IgG is the only …
Health disparities in allergic and immunologic conditions in racial and ethnic underserved populations: a Work Group Report of the AAAAI Committee on the …
Health disparities are health differences linked with economic, social, and environmental
disadvantage. They adversely affect groups that have systematically experienced greater …
disadvantage. They adversely affect groups that have systematically experienced greater …
Morbidity and mortality in common variable immune deficiency over 4 decades
ES Resnick, EL Moshier, JH Godbold… - Blood, The Journal …, 2012 - ashpublications.org
The demographics, immunologic parameters, medical complications, and mortality statistics
from 473 subjects with common variable immune deficiency followed over 4 decades in New …
from 473 subjects with common variable immune deficiency followed over 4 decades in New …